Assessing the impact of ICH E9.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 77, doi. 10.1002/pst.337
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2008 AND VI 7 AND IP 2
Results: 11
1
2
Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 93, doi. 10.1002/pst.267
- By:
- Publication type:
- Article
3
Literature review: January-March 2008.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 147, doi. 10.1002/pst.340
- By:
- Publication type:
- Article
4
Issues with using baseline in last observation carried forward analysis.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 142, doi. 10.1002/pst.311
- By:
- Publication type:
- Article
5
Basic statistics and pharmaceutical statistical applications (second edition), De Muth JE (2006), ISBN 0849337992; 714 pages; £39.99, $80.96 CRC;.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 151, doi. 10.1002/pst.307
- By:
- Publication type:
- Article
6
A two-stage phase II trial design utilizing both primary and secondary endpoints.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 88, doi. 10.1002/pst.255
- By:
- Publication type:
- Article
7
Book Review.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 150, doi. 10.1002/pst.306
- By:
- Publication type:
- Article
8
Recent advances in quantitative methods in Cancer and Human Health Risk Assessment Edler L, Kitsos CP (2005) ISBN: 0470857564; 463 pages; £70.00, €112.50, $105.00 Wiley;.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 152, doi. 10.1002/pst.317
- By:
- Publication type:
- Article
9
Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 130, doi. 10.1002/pst.287
- By:
- Publication type:
- Article
10
Weibull prediction of event times in clinical trials.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 107, doi. 10.1002/pst.271
- By:
- Publication type:
- Article
11
PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events.
- Published in:
- Pharmaceutical Statistics, 2008, v. 7, n. 2, p. 121, doi. 10.1002/pst.286
- By:
- Publication type:
- Article